By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting
Health

EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting

GlobeNews Wire
Last updated: 28/04/2026 10:37 PM
GlobeNews Wire
Published: 28/04/2026
Share
SHARE

EssilorLuxottica 2026 Annual Shareholders’ Meeting

  • All resolutions proposed by the Board of Directors adopted
  • Dividend of Euro 4.00 per share, with option for payment in shares

Paris, France (28 April 2026 – 6:00 pm CEST) – EssilorLuxottica Annual Shareholders’ Meeting was held today at 3 Mazarium in Paris. Shareholders approved all 30 resolutions submitted by the Board of Directors to the Ordinary and Extraordinary General Meeting, including the distribution of a Euro 4.00 dividend per share for the financial year 2025 and the compensation policy applicable to the Company’s Executive Corporate Officers.

“The trust expressed by our shareholders at today’s General Meeting reflects a shared belief in the profound transformation we’re delivering. Our clear and bold strategy, leveraging our expertise across vision care, wearables and building on our journey in med-tech, is already translating into tangible results, as evidenced by today’s approval of a Euro 4.00 dividend, nearly doubling since 2018. With the continued confidence of our shareholders, we’ll continue to lead with ambition and execute with excellence to create lasting value for all our stakeholders,” commented Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica after the Meeting.

Payment of the dividend and option for payment of the dividend in shares

The resolution granting shareholders the option to receive their final dividend to be paid for the financial year ended on December 31, 2025, in shares has also been approved. As duly acknowledged by the Board of Directors, the price for newly issued shares for the payment of the dividend has been set at Euro 175.06 per share.

  • This price corresponds to 90% of the average of the opening prices on Euronext Paris during the twenty trading days preceding the date of the Annual General Meeting less the amount of the final dividend to be distributed for the financial year ended on December 31, 2025, this total being rounded up to the next euro cent.
  • The ex-dividend date1 is set on May 5, 2026. The record date2 is set on May 6, 2026.

Shareholders will be entitled to opt for payment of the dividend in newly issued shares between May 7, 2026 and May 28, 2026, inclusive, (except for shareholders holding shares in pure registered form who have to exercise such option at the latest on May 26, 2026 by regular mail or May 27 via the website). To exercise such option, shareholders have to address their request to the authorized financial intermediaries. For shareholders holding shares in pure registered form, the request will have to be addressed to the Company’s agent (Uptevia, 90 – 110 Esplanade du Général de Gaulle – 92931 Paris La Défense Cedex). For shareholders who have not exercised their option by the abovementioned deadlines, the final dividend will be entirely paid in cash.

An application will be made to admit the new shares for trading on Euronext Paris market. The new ordinary shares allocated in payment will confer the same rights as the existing shares and carry current dividend rights (“jouissance courante”), i.e. they will confer the right to any distribution paid out as from the date of their issuance.

If the amount of the final dividend in respect of which the option will be exercised does not correspond to a whole number of shares, the shareholder will receive the number of shares rounded down to the nearest inferior whole number, and a balancing payment in cash (“soulte”).
The payment of the dividend or the delivery of the new shares following the exercise of the option will take place on June 3, 2026.

Shareholders may connect to www.essilorluxottica.com to consult the Questions & Answers dedicated to the payment of dividend in shares.

Forthcoming Shareholder Key Dates

  • Ex date1: May 5, 2026
  • Record date2: May 6, 2026
  • Period to exercise the option: May 7, 2026 to May 28, 2026, inclusive
  • Date of payment: June 3, 2026

Webcast of the Annual Shareholders’ Meeting

To access the replay webcast of the Annual General Meeting that will be made available at 6:30 pm CEST, please visit this link.

Notes
1 First date from which EssilorLuxottica shares are traded without the dividend rights.
2 Date on which positions are determined by the central securities depository at close of business.

  • DOWNLOAD THE PRESS RELEASE
Midea Showcases Transformative Innovations for ‘Master Your Home’ at IFA 2025
Ansell Receives Frost & Sullivan’s 2025 Global Sustainable Hospital Supplies Company of the Year Award
Byreal Expands Agent-Native Trading to Perpetual Futures with Byreal Perps Agent Skills
Creddinv ONE: Unified Wealth Platform Exceeds 100 Crore AUM in 3 Months
Aon enhances industry-leading Reinsurance team with executive appointments
TAGGED:2026annualessilorluxottica:FR0000121667meetingnewsParis:ELshareholders
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch
Health

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch

GlobeNews Wire
GlobeNews Wire
02/07/2025
Colorcon Celebrates Grand Opening of New Manufacturing Facility in Malaysia
The Future Now: adidas Reveals the CLIMACOOL LACED
OCI Global Completes Sale of OCI Methanol to Methanex Corporation
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?